Cytiva Completes Doubling of Utah Site’s Liquid Media Production Capacity
Cytiva has finalized an expansion of its Logan, UT, facility, effectively doubling its liquid media…
Newswire
FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy for Hematologic Malignancies
The U.S. Food and Drug Administration (FDA) has granted approval for an allogeneic regulatory T…
Lonza Expands HPAPI Capacity in Visp, Further Supporting its Position in Payload-Linker Manufacturing
Basel, Switzerland, – Lonza, a leading contract development and manufacturing organization (CDMO), today announced plans…
Anthropic Unveils Claude Science, Targeting Pharma Research Operations
SAN FRANCISCO — Anthropic, the artificial intelligence firm, on Tuesday announced the availability of Claude…
Duke University Engineers Develop iPSC-Derived Retinal Endothelial Cells for Disease Research
Biomedical engineers at Duke University have successfully utilized induced pluripotent stem cells (iPSCs) to cultivate…
Marburg outbreak reported in Uganda complicates ongoing Ebola response
Uganda has officially reported a Marburg disease outbreak to the World Health Organization, according to…
EAN 2026: New Fintepla Data in Dravet Syndrome and LGS
The recent trial data presented at EAN 2026 highlights the efficacy of Fintepla in treating…
Lilly and Regeneron Among First Incumbents to FDA’s Fast-Track Facility Scheme
Seven pharmaceutical companies, including Eli Lilly and Regeneron, have been selected for the FDA’s PreCheck…
Viridian may have edge over Amgen in eye drug showdown, analysts argue
The FDA has granted a new approval for Viridian’s drug, which analysts suggest could provide…
Top FDA gene and cell therapy regulator to step down
Vijay Kumar, a prominent figure in the FDA’s gene and cell therapy division, is set…